Tian'an Pharmaceutical Co., Ltd. (OTCPK: TNPH)
Health Care · Pharmaceuticals · CN
$—
— today · — 1Y
Tian'an Pharmaceutical Co., Ltd. (OTCPK: TNPH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $735.52K and employs 3 people.
trading between 0.00 and 0.05.
Tweenvest scores Tian'an Pharmaceutical Co., Ltd. across four factors: value 64/100. Its strongest factor is value.
TNPH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $735.52K
- Revenue (TTM)
- $10.65M
- P/E
- 0.04
- EPS
- 0.22
- Dividend yield
- —
- Beta (5Y)
- -2.04
- 52-week high
- $0.05
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 81.73M
- Employees
- 3
- Next earnings
- —
About Tian'an Pharmaceutical Co., Ltd.
Tian'an Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China. It also engages in the research and development of biology goods and health care products. The company's pharmaceutical and nutraceutical products include Compound Ginseng capsule, a Chinese medicine preparation that is used to cure and treat prostate gland proliferation; Nizhuanle Yin granule, a Chinese medicine preparation that treats the decomposition or inflammation of the stomach's mucous membrane; and Tianan soft capsule, which is used to adjust high amounts of fat in the blood stream, improve blood vessel ventilation, and soften blood vessels. Its products also include Tianan Pain Relief Capsule, a Chinese medicine preparation, which is under development to cure pain in joints, headache, pain from muscle injury, cancer, and gynecological disorders, as well as general pain. Tian' An Pharmaceutical sells its products to independent distributors, who sell products to pharmacies and drugstores, and hospitals. The company was founded in 2003 and is based in Xi'an, China.
- ISIN
- US88631V1035
- Founded
- 2003
- Listed since
- Jun 22, 2007
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.